Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Assessing risk for Mendelian disorders in a Bronx population.

diSibio G, Upadhyay K, Meyer P, Oddoux C, Ostrer H.

Mol Genet Genomic Med. 2017 Jul 6;5(5):516-523. doi: 10.1002/mgg3.307. eCollection 2017 Sep.

2.

The genetic history of Cochin Jews from India.

Waldman YY, Biddanda A, Dubrovsky M, Campbell CL, Oddoux C, Friedman E, Atzmon G, Halperin E, Ostrer H, Keinan A.

Hum Genet. 2016 Oct;135(10):1127-43. doi: 10.1007/s00439-016-1698-y. Epub 2016 Jul 4.

3.

The Genetics of Bene Israel from India Reveals Both Substantial Jewish and Indian Ancestry.

Waldman YY, Biddanda A, Davidson NR, Billing-Ross P, Dubrovsky M, Campbell CL, Oddoux C, Friedman E, Atzmon G, Halperin E, Ostrer H, Keinan A.

PLoS One. 2016 Mar 24;11(3):e0152056. doi: 10.1371/journal.pone.0152056. eCollection 2016.

4.

Response to Zlotogora and Meiner.

Baskovich B, Hiraki S, Oddoux C, Ostrer H, Upadhyay K.

Genet Med. 2016 May;18(5):530. doi: 10.1038/gim.2015.170. Epub 2015 Dec 10. No abstract available.

PMID:
26656652
5.

Expanded genetic screening panel for the Ashkenazi Jewish population.

Baskovich B, Hiraki S, Upadhyay K, Meyer P, Carmi S, Barzilai N, Darvasi A, Ozelius L, Peter I, Cho JH, Atzmon G, Clark L, Yu J, Lencz T, Pe'er I, Ostrer H, Oddoux C.

Genet Med. 2016 May;18(5):522-8. doi: 10.1038/gim.2015.123. Epub 2015 Sep 3.

6.

A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes.

Kerns SL, Guevara-Aguirre J, Andrew S, Geng J, Guevara C, Guevara-Aguirre M, Guo M, Oddoux C, Shen Y, Zurita A, Rosenfeld RG, Ostrer H, Hwa V, Dauber A.

J Clin Endocrinol Metab. 2014 Oct;99(10):E2117-22. doi: 10.1210/jc.2014-1949. Epub 2014 Jul 24.

7.

Prostate cancer susceptibility genes on 8p21-23 in a Dutch population.

Zeegers MP, Nekeman D, Khan HS, van Dijk BA, Goldbohm RA, Schalken J, Shajahan S, Pearlman A, Oddoux C, van den Brandt PA, Schouten LJ, Ostrer H.

Prostate Cancer Prostatic Dis. 2013 Sep;16(3):248-53. doi: 10.1038/pcan.2013.9. Epub 2013 Apr 30.

PMID:
23628848
8.

The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies.

Sarsour K, Greenberg J, Johnston JA, Nelson DR, O'Brien LA, Oddoux C, Ostrer H, Pearlman A, Reed G.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):189-94. Epub 2012 Dec 13.

PMID:
23294992
9.

North African Jewish and non-Jewish populations form distinctive, orthogonal clusters.

Campbell CL, Palamara PF, Dubrovsky M, Botigué LR, Fellous M, Atzmon G, Oddoux C, Pearlman A, Hao L, Henn BM, Burns E, Bustamante CD, Comas D, Friedman E, Pe'er I, Ostrer H.

Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13865-70. doi: 10.1073/pnas.1204840109. Epub 2012 Aug 6.

10.

KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.

Liu X, Gomez-Pinillos A, Loder C, Carrillo-de Santa Pau E, Qiao R, Unger PD, Kurek R, Oddoux C, Melamed J, Gallagher RE, Mandeli J, Ferrari AC.

Am J Pathol. 2012 Sep;181(3):1007-16. doi: 10.1016/j.ajpath.2012.06.008. Epub 2012 Jul 20.

11.

The impact of Converso Jews on the genomes of modern Latin Americans.

Velez C, Palamara PF, Guevara-Aguirre J, Hao L, Karafet T, Guevara-Aguirre M, Pearlman A, Oddoux C, Hammer M, Burns E, Pe'er I, Atzmon G, Ostrer H.

Hum Genet. 2012 Feb;131(2):251-63. doi: 10.1007/s00439-011-1072-z. Epub 2011 Jul 26.

PMID:
21789512
12.

Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.

Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, Ostrer H, Mantzoros C, Pasche B.

Metabolism. 2011 Sep;60(9):1234-43. doi: 10.1016/j.metabol.2011.01.005. Epub 2011 Mar 12.

13.

Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination.

Pearlman A, Loke J, Le Caignec C, White S, Chin L, Friedman A, Warr N, Willan J, Brauer D, Farmer C, Brooks E, Oddoux C, Riley B, Shajahan S, Camerino G, Homfray T, Crosby AH, Couper J, David A, Greenfield A, Sinclair A, Ostrer H.

Am J Hum Genet. 2010 Dec 10;87(6):898-904. doi: 10.1016/j.ajhg.2010.11.003.

14.

Genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population: DG8S737 may not be the causative variant.

Zeegers MP, Khan HS, Schouten LJ, van Dijk BA, Goldbohm RA, Schalken J, Shajahan S, Pearlman A, Oddoux C, van den Brandt PA, Ostrer H.

Eur J Hum Genet. 2011 Jan;19(1):118-20. doi: 10.1038/ejhg.2010.133. Epub 2010 Aug 11.

15.

Copy number and gene expression differences between African American and Caucasian American prostate cancer.

Rose AE, Satagopan JM, Oddoux C, Zhou Q, Xu R, Olshen AB, Yu JZ, Dash A, Jean-Gilles J, Reuter V, Gerald WL, Lee P, Osman I.

J Transl Med. 2010 Jul 22;8:70. doi: 10.1186/1479-5876-8-70.

16.

Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry.

Atzmon G, Hao L, Pe'er I, Velez C, Pearlman A, Palamara PF, Morrow B, Friedman E, Oddoux C, Burns E, Ostrer H.

Am J Hum Genet. 2010 Jun 11;86(6):850-9.

17.

MDM2 expression and regulation in prostate cancer racial disparity.

Wang G, Firoz EF, Rose A, Blochin E, Christos P, Pollens D, Mazumdar M, Gerald W, Oddoux C, Lee P, Osman I.

Int J Clin Exp Pathol. 2009;2(4):353-60. Epub 2008 Dec 4.

18.

Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk.

Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, Ahsan H, Pasche B, Mantzoros C.

Cancer Res. 2008 May 1;68(9):3178-84. doi: 10.1158/0008-5472.CAN-08-0533.

19.

Novel mutations of epidermal growth factor receptor in localized prostate cancer.

Douglas DA, Zhong H, Ro JY, Oddoux C, Berger AD, Pincus MR, Satagopan JM, Gerald WL, Scher HI, Lee P, Osman I.

Front Biosci. 2006 Sep 1;11:2518-25.

PMID:
16720329
20.

Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.

Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, Bradley C, Hegarty C, McDaniel B, Rademaker A, Oddoux C, Ostrer H, Michel LS, Huang H, Chen Y, Ahsan H, Offit K, Pasche B.

Cancer Res. 2005 Apr 15;65(8):3454-61. Erratum in: Cancer Res. 2006 Mar 15;66(6):3345.

21.

No major association between TGFBR1*6A and prostate cancer.

Kaklamani V, Baddi L, Rosman D, Liu J, Ellis N, Oddoux C, Ostrer H, Chen Y, Ahsan H, Offit K, Pasche B.

BMC Genet. 2004 Sep 22;5:28.

22.

The frequency of GJB2 and GJB6 mutations in the New York State newborn population: feasibility of genetic screening for hearing defects.

Fitzgerald T, Duva S, Ostrer H, Pass K, Oddoux C, Ruben R, Caggana M.

Clin Genet. 2004 Apr;65(4):338-42.

PMID:
15025729
23.

A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome.

Ben-Yosef T, Ness SL, Madeo AC, Bar-Lev A, Wolfman JH, Ahmed ZM, Desnick RJ, Willner JP, Avraham KB, Ostrer H, Oddoux C, Griffith AJ, Friedman TB.

N Engl J Med. 2003 Apr 24;348(17):1664-70. No abstract available.

24.

Identification of the first non-Jewish mutation in familial Dysautonomia.

Leyne M, Mull J, Gill SP, Cuajungco MP, Oddoux C, Blumenfeld A, Maayan C, Gusella JF, Axelrod FB, Slaugenhaupt SA.

Am J Med Genet A. 2003 May 1;118A(4):305-8.

PMID:
12687659
25.

Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.

Offit K, Gilad S, Paglin S, Kolachana P, Roisman LC, Nafa K, Yeugelewitz V, Gonzales M, Robson M, McDermott D, Pierce HH, Kauff ND, Einat P, Jhanwar S, Satagopan JM, Oddoux C, Ellis N, Skaliter R, Yahalom J.

Clin Cancer Res. 2002 Dec;8(12):3813-9.

26.

SRY gene expression in the ovotestes of XX true hermaphrodites.

Ortenberg J, Oddoux C, Craver R, McElreavey K, Salas-Cortes L, Guillen-Navarro E, Ostrer H, Sarafoglou K, Clarke V, Yee H.

J Urol. 2002 Apr;167(4):1828-31. Erratum in: J Urol 2002 Oct;168(4 Pt 1):1510.

PMID:
11912443
27.

Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function.

Kurima K, Peters LM, Yang Y, Riazuddin S, Ahmed ZM, Naz S, Arnaud D, Drury S, Mo J, Makishima T, Ghosh M, Menon PS, Deshmukh D, Oddoux C, Ostrer H, Khan S, Riazuddin S, Deininger PL, Hampton LL, Sullivan SL, Battey JF Jr, Keats BJ, Wilcox ER, Friedman TB, Griffith AJ.

Nat Genet. 2002 Mar;30(3):277-84. Epub 2002 Feb 19.

PMID:
11850618
28.

Mendelian diseases among Roman Jews: implications for the origins of disease alleles.

Oddoux C, Guillen-Navarro E, Ditivoli C, Dicave E, Cilio MR, Clayton CM, Nelson H, Sarafoglou K, McCain N, Peretz H, Seligsohn U, Luzzatto L, Nafa K, Nardi M, Karpatkin M, Aksentijevich I, Kastner D, Axelrod F, Ostrer H.

J Clin Endocrinol Metab. 1999 Dec;84(12):4405-9. Review.

PMID:
10599695
29.

TbetaR-I(6A) is a candidate tumor susceptibility allele.

Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, Lo RS, Brener D, Yang D, Kirstein L, Oddoux C, Ostrer H, Vineis P, Varesco L, Jhanwar S, Luzzatto L, Massagué J, Offit K.

Cancer Res. 1999 Nov 15;59(22):5678-82.

30.

Prevalence of Bloom syndrome heterozygotes among Ashkenazi Jews.

Oddoux C, Clayton CM, Nelson HR, Ostrer H.

Am J Hum Genet. 1999 Apr;64(4):1241-3. No abstract available.

31.

Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.

Aksentijevich I, Torosyan Y, Samuels J, Centola M, Pras E, Chae JJ, Oddoux C, Wood G, Azzaro MP, Palumbo G, Giustolisi R, Pras M, Ostrer H, Kastner DL.

Am J Hum Genet. 1999 Apr;64(4):949-62.

32.

Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness.

Morell RJ, Kim HJ, Hood LJ, Goforth L, Friderici K, Fisher R, Van Camp G, Berlin CI, Oddoux C, Ostrer H, Keats B, Friedman TB.

N Engl J Med. 1998 Nov 19;339(21):1500-5.

33.

Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.

Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, Huttley GA, Allikmets R, Schriml L, Gerrard B, Malasky M, Ramos MD, Morlot S, Tzetis M, Oddoux C, di Giovine FS, Nasioulas G, Chandler D, Aseev M, Hanson M, Kalaydjieva L, Glavac D, Gasparini P, Kanavakis E, Claustres M, Kambouris M, Ostrer H, Duff G, Baranov V, Sibul H, Metspalu A, Goldman D, Martin N, Duffy D, Schmidtke J, Estivill X, O'Brien SJ, Dean M.

Am J Hum Genet. 1998 Jun;62(6):1507-15.

34.

X-inactivation and cytogenetic studies in a family with sensorineural hearing loss and Turner syndrome.

Sculerati N, Perle MA, Oddoux C, Clayton CM, Ostrer H.

Otolaryngol Head Neck Surg. 1997 Dec;117(6):S221-5. No abstract available.

PMID:
9419154
35.

Severe factor XI deficiency in an Arab family associated with a novel mutation in exon 11.

Wistinghausen B, Reischer A, Oddoux C, Ostrer H, Nardi M, Karpatkin M.

Br J Haematol. 1997 Dec;99(3):575-7.

PMID:
9401068
36.

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B.

Nat Genet. 1997 Sep;17(1):79-83.

PMID:
9288102
37.

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.

Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K.

Nat Genet. 1996 Oct;14(2):188-90.

PMID:
8841192
38.

High-level inducible expression of visual pigments in transfected cells.

Kazmi MA, Dubin RA, Oddoux C, Ostrer H.

Biotechniques. 1996 Aug;21(2):304-11.

39.

Hearing loss in Turner syndrome.

Sculerati N, Oddoux C, Clayton CM, Lim JW, Oster H.

Laryngoscope. 1996 Aug;106(8):992-7.

PMID:
8699915
40.

Prevalence of Canavan disease heterozygotes in the New York metropolitan Ashkenazi Jewish population.

Kronn D, Oddoux C, Phillips J, Ostrer H.

Am J Hum Genet. 1995 Nov;57(5):1250-2. No abstract available.

41.

Prenatal diagnostic testing for familial dysautonomia using linked genetic markers.

Oddoux C, Reich E, Axelrod F, Blumenfeld A, Maayan C, Slaugenhaupt S, Gusella J, Ostrer H.

Prenat Diagn. 1995 Sep;15(9):817-26.

PMID:
8559751
42.

Renin gene promoter activity in GC cells is regulated by cAMP and thyroid hormone through Pit-1-dependent mechanisms.

Gilbert MT, Sun J, Yan Y, Oddoux C, Lazarus A, Tansey WP, Lavin TN, Catanzaro DF.

J Biol Chem. 1994 Nov 11;269(45):28049-54.

44.

Fibrinogen assembly: insights from chicken hepatocytes.

Oddoux C, Grieninger G.

Hepatology. 1994 Mar;19(3):688-93.

PMID:
8119694
45.
46.

Characterization of the chicken apolipoprotein A-I gene 5'-flanking region.

Bhattacharyya N, Chattapadhyay R, Oddoux C, Banerjee D.

DNA Cell Biol. 1993 Sep;12(7):597-604.

PMID:
8397817
47.

Promoter activity of human renin 5'-flanking DNA sequences is activated by the pituitary-specific transcription factor Pit-1.

Sun J, Oddoux C, Lazarus A, Gilbert MT, Catanzaro DF.

J Biol Chem. 1993 Jan 25;268(3):1505-8.

48.

Carboxy-terminal-extended variant of the human fibrinogen alpha subunit: a novel exon conferring marked homology to beta and gamma subunits.

Fu Y, Weissbach L, Plant PW, Oddoux C, Cao Y, Liang TJ, Roy SN, Redman CM, Grieninger G.

Biochemistry. 1992 Dec 8;31(48):11968-72.

PMID:
1457396
49.

Assembly and secretion of fibrinogen. Degradation of individual chains.

Roy S, Yu S, Banerjee D, Overton O, Mukhopadhyay G, Oddoux C, Grieninger G, Redman C.

J Biol Chem. 1992 Nov 15;267(32):23151-8.

50.

The beta chain of chicken fibrinogen contains an atypical thrombin cleavage site.

Weissbach L, Oddoux C, Procyk R, Grieninger G.

Biochemistry. 1991 Apr 2;30(13):3290-4.

PMID:
2009266

Supplemental Content

Loading ...
Support Center